EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

STATE REGULATION OF MEDICINE PRICES IN UKRAINE: REFERENCE-PRICING CYCLES AND CHANGES IN DECLARED CEILING PRICES

Yuliya Pereguda

Economic Scope · 26.10.2026 · (218) · 121-127

DOI: 10.30838/ep.218.121-127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Economic Scope, online erschienen am 26.10.2026. Verfasst von Yuliya Pereguda. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The article examines the institutional and economic meaning of temporal misalignment between external reference pricing and the declaration of maximum wholesale release prices for medicines in Ukraine and tests how the unit of aggregation affects descriptive results. Legal, documentary, chronological and descriptive-statistical methods were applied. Eleven Ministry of Health price-declaration orders issued between 21 January and 14 August 2026 were analysed together with the preceding Order No. 1959 of 26 December 2025 as the baseline for the first interval. The mean interval between the eleven 2026 orders was 21.0 days and the median was 19 days. For ROXERA®, the previous reference-price limits for 10 mg No. 90, 15 mg No. 30 and 20 mg No. 90 equalled the simultaneously valid declared ceilings. On 6 August 2026 the reference limits increased to UAH 448.11, 152.62 and 420.53, while the declared ceilings remained UAH 423.52, 144.26 and 400.92. Accordingly, the regulatory gap rose from zero to UAH 24.59, 8.36 and 19.61, and the ratio of the declared ceiling to the reference limit fell from 1.000 to 0.945, 0.945 and 0.953. This change in only one of the two simultaneously valid administrative limits provides direct evidence of temporal misalignment. Before the amendments introduced by Cabinet of Ministers Resolution No. 1064 took effect, the procedure did not establish a separate deadline for bringing a declared ceiling into line with a changed reference limit; the amendment introduced a 30-day period. For Order No. 877, an analytical set of 33 paired “before–after” declared-price changes across eight trade names was used to test aggregation sensitivity. The line-item mean was 12.3%, while the unweighted mean across trade-name groups was 11.7%; treating names with and without the ® sign as separate groups yielded 12.0%. Thus, the choice of aggregation unit changes the descriptive mean by 0.3–0.6 percentage points. The findings show that analysis of administrative price data requires dated pairs of simultaneously valid reference and declared limits and an explicit aggregation rule. Transaction prices are outside the scope of the public administrative dataset.

Zitieren

APA

Pereguda, Y. (2026). STATE REGULATION OF MEDICINE PRICES IN UKRAINE: REFERENCE-PRICING CYCLES AND CHANGES IN DECLARED CEILING PRICES. Economic Scope, 121-127. https://doi.org/10.30838/ep.218.121-127

Vancouver

Pereguda Y. STATE REGULATION OF MEDICINE PRICES IN UKRAINE: REFERENCE-PRICING CYCLES AND CHANGES IN DECLARED CEILING PRICES. Economic Scope. 2026:121-127. doi:10.30838/ep.218.121-127

BibTeX
@article{Pereguda2026,
  author = {Pereguda, Yuliya},
  title = {STATE REGULATION OF MEDICINE PRICES IN UKRAINE: REFERENCE-PRICING CYCLES AND CHANGES IN DECLARED CEILING PRICES},
  journal = {Economic Scope},
  year = {2026},
  number = {218},
  pages = {121--127},
  doi = {10.30838/ep.218.121-127}
}
Kostenlos starten →